Ohio House Bill HB462

Ohio 2025-2026 Regular Session

• Introduced: 9/23/25
• Report Pass: 11/5/25
• Engrossed: 11/12/25
• Report Pass: 3/25/26
• Enrolled: 4/15/26

Caption

Regards student use of a nasal epinephrine delivery device

Impact

The implementation of HB 462 is expected to modify existing state laws regarding the management of allergies in educational settings. This includes establishing protocols for the trained personnel who will be responsible for administering the nasal epinephrine delivery device. The bill is anticipated to lead to greater awareness and preparedness among school staff, fostering a safer environment for allergic students. As laws adapt to include stipulations on medical devices in schools, the bill also reflects a growing recognition of the importance of addressing health issues in educational settings proactively.

Summary

House Bill 462 addresses the use of nasal epinephrine delivery devices in schools, aimed at ensuring that students who experience severe allergic reactions have immediate access to this essential medical intervention. The provisions of the bill are intended to enhance the safety of students with known allergies, particularly those at risk of anaphylaxis. By allowing designated school personnel to administer nasal epinephrine, the bill seeks to provide timely assistance during emergencies where traditional medical help may be delayed, thereby potentially saving lives.

Sentiment

The overall sentiment towards HB 462 has been favorable, particularly among parents, healthcare advocates, and school officials, who see the importance of equipping schools to handle medical emergencies related to allergies. Supporters laud the bill for its proactive approach in safeguarding student health, which is seen as essential in preventing potentially life-threatening situations. However, there may be concerns regarding the readiness and training of school staff to competently manage emergency health situations, which could be a point of contention among critics who advocate for more comprehensive training and resources.

Contention

While the primary focus of the bill is on enhancing emergency responses to allergic reactions, potential areas of contention may arise regarding the adequacy of training for school personnel and the resources allocated to implement this bill effectively. Critics might argue that simply allowing the administration of nasal epinephrine does not address the broader issue of allergy management within schools, which may require additional measures such as awareness programs and ensuring on-site access to medical care. The success of the bill will largely depend on its practical implementation and the willingness of schools to adopt the proposed changes effectively.